Publikace
- Single-agent cytarabine is insufficient for the treatment of human mantle cell lymphoma in mouse xenograft model2016 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents2014 | 1. lékařská fakulta
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové, 3. lékařská fakulta
- Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas2022 | 1. lékařská fakulta, 2. lékařská fakulta, Lékařská fakulta v Plzni, Fakulta tělesné výchovy a sportu
- Quantitative In Vivo Monitoring of Hypoxia and Vascularization of Patient-Derived Murine Xenografts of Mantle Cell Lymphoma Using Photoacoustic and Ultrasound Imaging2021 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma2021 | 1. lékařská fakulta
- CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement2021 | 1. lékařská fakulta
- Dimethyl fumarate induces ferroptosis and impairs NF-kappa B/STAT3 signaling in DLBCL2021 | 1. lékařská fakulta
- Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma2020 | 1. lékařská fakulta, 2. lékařská fakulta
- Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab2020 | 1. lékařská fakulta
Loading network view...